Schorno Dean L
Schorno Dean L, EVP, CFO, reported a transaction classified as exercise at RIGEL PHARMACEUTICALS INC involving 1286.000000 shares for an estimated $31121.20. Reported holdings after the transaction were 82962.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Sep 02, 2026
- Filing date
- Sep 03, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
RIGL price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0000905148-26-004080 Common Stock
- Transaction date
- Sep 02, 2026 Filed Sep 03, 2026, 11:02 PM · 1d delay
- Shares
- 1,286 sh $24.20 per share
- Estimated value
- $31.1k Computed from shares × price
- Holdings after
- 82,962 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
EVP & Chief Financial Officer
- F1
Includes 500 shares acquired under the Issuer's stock purchase plan.
- F2
These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- F3
The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the I…
- F4
The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Iss…
- F5
The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the Reporting Person's continuous service to the I…
- F6
The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2020, subject to the Reporting Person's continuous service to the I…
0 other transactions
0 recent txs